ARK Genomic Revolution fund starts position in Burning Rock Biotech

Published Nov 17 2021 at 8:56 AM GMT
  • The ARK Genomic Revolution ETF started a position in Burning Rock Biotech , a Chinese cancer sequencing technology company that jumped 11% after reporting third-quarter results.
  • The loss-making biotech saw its revenue edge up 2% in the third quarter and is planning two products for early-stage cancer patients next year.
  • In other moves, two Ark funds sold nearly $23 million worth of Unity Software , while the ARK Next Generation Internet ETF continued to boost its holding in Robinhood Markets .Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move.
  • Visit MarketWatch com for more information on this news.



  • Published Nov 17, 2021 8:56 AM GMT